Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy
Guillaume Berton(Hôpital de la Conception), Geoffroy Venton(Inserm), Anne-Laure Couderc(Assistance Publique Hôpitaux de Marseille), Robin Arcani(Inserm), Laure Farnault(Aix-Marseille Université), Régis Costello(Inserm), Julien Colle(Inserm), Vadim Ivanov(Hôpital de la Conception), Pauline Roché(Hôpital de la Conception), David Taïeb(Aix-Marseille Université), Cédric Mercier(Inserm), Antoine Tichadou(Assistance Publique Hôpitaux de Marseille)
Cited by 0
Related Papers
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
|Nature Reviews Endocrinology|2021|167
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
<sup>18</sup>F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
|Journal of Nuclear Medicine|2009|126